Moreover, such curcumin immunoconjugates were shown to kill specifically tumor cells bearing the CD33 marker expressed by acute myeloid leukemia (AML) cells in patients synthetizing and expressing hCGβ on the cellular membrane. The gene discussed is CD33; the disease is acute myeloid leukemia.